Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CivaTech Oncology
This registry is being conducted to provide long term analysis on the use of the linear Civastring source for prostate cancer. Prospective data collection will record and demonstrate biochemical response rates. Long term side effects and adverse events will be monitored.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Age \> 18 years old
Plans to remain in care of enrolling physician for 5 years
\> 5 years life expectancy
Signed informed consent
Enrolled within 6 weeks of implant or within 365 days of prior implant
You may not be if
Not willing or able to comply with protocol visit schedule
Clareo Health | Linear Source Registry for Prostate Cancer
